Literature DB >> 15929802

Recent results and ongoing trials with panitumumab (ABX-EGF), a fully human anti-epidermal growth factor receptor antibody, in metastatic colorectal cancer.

Preeta Tyagi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15929802     DOI： 10.1016/s1533-0028(11)70161-x

Source DB:  PubMed          Journal:  Clin Colorectal Cancer        ISSN： 1533-0028            Impact factor:   4.481


× No keyword cloud information.
  8 in total

1.  Increasing age-related survival gap among patients with colorectal cancer: a population-based retrospective study.

Authors:  Yang Feng; Shaobo Mo; Weixing Dai; Qingguo Li; Guoxiang Cai; Sanjun Cai
Journal:  Int J Clin Oncol       Date:  2019-09-17       Impact factor: 3.402

Review 2.  A New Antitumor Direction: Tumor-Specific Endothelial Cells.

Authors:  Jing Liang; Shouqi Wang; Guowei Zhang; Baoyu He; Qingli Bie; Bin Zhang
Journal:  Front Oncol       Date:  2021-12-20       Impact factor: 6.244

3.  Targeting the tumor microenvironment: focus on angiogenesis.

Authors:  Fengjuan Fan; Alexander Schimming; Dirk Jaeger; Klaus Podar
Journal:  J Oncol       Date:  2011-08-24       Impact factor: 4.375

4.  A Novel Anti-EGFR mAb Ame55 with Lower Toxicity and Better Efficacy than Cetuximab When Combined with Irinotecan.

Authors:  Weiyi Qiu; Chang Zhang; Shuang Wang; Xiaoyan Yu; Qiong Wang; Dadi Zeng; Peng Du; Jinling Ma; Yiqiong Zheng; Bo Pang; Yunzhou Yu; Feng Long; Xiaobin Pang; Zhiwei Sun
Journal:  J Immunol Res       Date:  2019-01-13       Impact factor: 4.818

5.  Development of broadly neutralizing antibodies targeting the cytomegalovirus subdominant antigen gH.

Authors:  Andrea J Parsons; Sabrina I Ophir; J Andrew Duty; Thomas A Kraus; Kathryn R Stein; Thomas M Moran; Domenico Tortorella
Journal:  Commun Biol       Date:  2022-04-25

6.  Tumor biology and cancer therapy - an evolving relationship.

Authors:  Thomas Seufferlein; Johann Ahn; Denis Krndija; Ulrike Lother; Guido Adler; Götz von Wichert
Journal:  Cell Commun Signal       Date:  2009-08-13       Impact factor: 5.712

Review 7.  Development of therapeutic antibodies for the treatment of diseases.

Authors:  Ruei-Min Lu; Yu-Chyi Hwang; I-Ju Liu; Chi-Chiu Lee; Han-Zen Tsai; Hsin-Jung Li; Han-Chung Wu
Journal:  J Biomed Sci       Date:  2020-01-02       Impact factor: 8.410

8.  A universal in silico V(D)J recombination strategy for developing humanized monoclonal antibodies.

Authors:  Yuan-Chin Hsieh; Jun-Min Liao; Kuo-Hsiang Chuang; Kai-Wen Ho; Shih-Ting Hong; Hui-Ju Liu; Bo-Cheng Huang; I-Ju Chen; Yen-Ling Liu; Jaw-Yuan Wang; Hsiang-Lin Tsai; Yu-Cheng Su; Yen-Tseng Wang; Tian-Lu Cheng
Journal:  J Nanobiotechnology       Date:  2022-01-31       Impact factor: 9.429
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.